Home » Stocks » HF Enterprises

HF Enterprises, Inc. (HFEN)

HF Enterprises will go public soon, but the exact IPO date is still unknown.
Stock Price: $6.00 - $7.00
Current IPO price range

Stock Price Chart

Key Info

Market Cap 58.50M
Revenue (ttm) 11.65M
Net Income (ttm) -842,261
Shares Out 9.00M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

More Stats

Market Cap 58.50M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 9.00M
Float n/a
EPS (basic) n/a
EPS (diluted) -0.09
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield -1.44%
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 5.02
PB Ratio n/a
Revenue 11.65M
Operating Income n/a
Net Income -842,261
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin -7.23%
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0
What these ratings mean

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018
Revenue24.2620.38
Revenue Growth19.02%-
Net Income / Loss-5.23-4.99
Numbers in millions USD.

Company Profile

Company Details

Full Name HF Enterprises, Inc.
Country United States
Employees 20
CEO Chan Heng Fai

Stock Information

Ticker Symbol HFEN
Stock Exchange NASDAQ
Industry Real Estate
Unique Identifier NASDAQ: HFEN
IPO Date Pending

Description

HF Enterprises is a diversified holding company principally engaged through its subsidiaries in property development, digital transformation technology and biohealth activities with operations in the United States, Singapore, Hong Kong, Australia and South Korea. We manage our three principal businesses primarily through our subsidiary, Alset International Limited (formerly known as Singapore eDevelopment Limited and referred to herein as “Alset International”), a public company traded on the Singapore Stock Exchange. Through this subsidiary (and indirectly, through other public and private U.S. and Asian subsidiaries), we are actively developing two significant real estate projects near Houston, Texas and in Frederick, Maryland in our property development segment. We have designed applications for enterprise messaging and e-commerce software platforms in the United States and Asia in our digital transformation technology business unit. Our recent foray into the biohealth segment includes research to treat neurological and immune-related diseases, nutritional chemistry to create a natural sugar alternative, research regarding innovative products to slow the spread of disease, and natural foods and supplements. We opportunistically identify global businesses for acquisition, incubation and corporate advisory services, primarily related to our existing operating business segments.